Association of Reproductive Health Professionals (ARHP)
Interstitial Cystitis Association ( ICA)

Screening, Treatment, and Management of IC/PBS

Scroll down for a link to the archived sessions

Web Faculty Bios

• Lee Shulman, MD: His major research focus is in reproductive genetics, contraception, botanical interventions in women’s health and medical education. He is currently Professor and Chief of the Division of Reproductive Genetics in the Department of Obstetrics and Gynecology at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Medical Director of the Graduate Program in Genetic Counseling at Northwestern University.
• Robert Moldwin, MD : He has research and clinical interest in bladder-based diseases – ranging from urinary incontinence to bladder pain syndromes and bladder infections. He is currently physician in charge of Urologic Infectious/ Inflammatory Diseases and Director of the Pelvic Pain Center at Long Island Jewish Medical Center in New Hyde Park, NY. He is also Associate Professor of Clinical Urology at Albert Einstein College of Medicine.
• Kristene Whitmore, MD: She is an IC pioneer and Founder and Director of the Pelvic and Sexual Health Institute at Graduate Hospital in Philadelphia, where she also serves as Chairman of the Division of Urology and President of the Medical Staff. She is currently Chair of Urology at Drexel University College of Medicine.

Accreditation Information

The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this continuing medical education activity for 1 credit hour in Category 1 of the Physician's Recognition Award of the American Medical Association. This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for 1.0 contact hour, including 0.75 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing. ARHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The assigned universal program number is 463-999-08-004-H01-P. This program provides 1 (0.1 CEUs) contact hour of continuing education credit.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals and the Interstitial Cystitis Association.

Funding Information  

The project has been made possible through an independent educational grant from
Ortho Women's Health and Urology.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Web Faculty Disclosures

• Lee P. Shulman, MD: Receives grants/research support from Duramed and Wyeth; consultant for Ortho-McNeil, Bayer HealthCare, Barr-Duramed, and Organon; speaker for Merck, Wyeth, Bayer HealthCare, Warner-Chilcott, Pfizer, Organon, and GSK-Roche
• Robert Moldwin, MD: Receives grants/research support from Plethora Pharmaceuticals; consultant for Ortho-McNeil and Allergan; speaker for Ortho-McNeil
• Kristene Whitmore , MD : Receives research support from Advance of Bionics, Medtronic, OrthoMcNeil, Pfizer, Yamanouchi; is an advisor for Boston Scientific, Lilly/Boehringer-Ingelheim, Medtronic, OrthoMcNeil; is a speaker for Lilly/Boehringer-Ingelheim, OrthoMcNeil, Pfizer, and Yamanouchi  

Advisory Committee Disclosures

• David Burks, MD: has no affiliations to disclose
• Michael Chancellor, MD : Receives grants/research support from Astellas, Pfizer, Cook, and Allergan; consultant for Astellas, Pfizer, Cook, and Allergan
• Robert Evans, MD: Consultant for Ortho Women’s Health & Urology, Astellas, Indevus, Medtronic ANS, and Cook; speaker for Ortho Women’s Health & Urology, Astellas and Indevus
• Philip Hanno, MD: Consultant for Astellas and Indevus
• Fred Howard, MD: Consultant for Ethicon Women’s Healthy & Urology and Ortho Women’s Health & Urology
• Mary W.L. Lee, PharmD, BCPS, FCCP: has no affiliations to disclose
• Robert Moldwin, MD: Receives grants/research support from Plethora Pharmaceuticals; consultant for Ortho-McNeil and Allergan; speaker for Ortho-McNeil
• Diane K Newman, RNC, MSN, CRNP, FAAN: has no affiliations to disclose
• Kenneth Peters, MD: Consultant for Medtronic
• Lee P. Shulman, MD: Receives grants/research support from Duramed and Wyeth; consultant for Ortho-McNeil, Bayer HealthCare, Barr-Duramed, and Organon; speaker for Merck, Wyeth, Bayer HealthCare, Warner-Chilcott, Pfizer, Organon, and GSK-Roche
• Diane A. Smith, MSN, CRNP: Consultant for Colpexin Sphere; speaker for Watson and Novartis
• Vicki Ratner, MD: Receives grants/research support from Medtronic and Ortho Women’s Health & Urology
• Kristene Whitmore , MD : receives research support from Advance of Bionics, Medtronic, OrthoMcNeil, Pfizer, Yamanouchi; is an advisor for Boston Scientific, Lilly/Boehringer-Ingelheim, Medtronic, OrthoMcNeil; is a speaker for Lilly/Boehringer-Ingelheim, OrthoMcNeil, Pfizer, and Yamanouchi

ARHP Staff/Consultant Disclosures

• Shama Alam, MScPH, Ann Chestnut, Libby Mullin, Diane Shannon, MD, MPH, Wayne Shields, Amy Swann, MA, and Allison Tombros, MHS have no affiliations to disclose

Click here to view archived session